Astrazeneca Plc (AZN)
$53.87 0.32 (0.59%)
11:15 EDT AZN Stock Quote Delayed 30 Minutes
Previous Close $54.19
Market Cap 136.47B
PE Ratio 48.63
Volume (Avg. Vol.) 1.69M
Day's Range 53.87 - 54.99
52-Week Range 36.15 - 57.44
Dividend & Yield 1.37 (2.54%)
AZN Stock Predictions, Articles, and Astrazeneca Plc News
- From InvestorPlace
- From the Web
These international stocks offer investors geographically diversified exposure and get a bigger bump as countries open up for business.
Lululemon Athletica, Nvidia, TJX Companies and AstraZeneca were our top stock trades for Friday. That said, let's look at the charts.
By Ian Cooper
There’s no reason Amarin stock won’t become a big success with Vascepa, especially with access to millions of patients.
Amarin is targeting a huge market, and its main drug -- Vascepa -- is likely to be expanded in its coverage. Here’s a look at what’s ahead for the stock.
There's a new Sanofi CEO preparing to join the company with current CEO Olivier Brandicourt retiring at the end of August.
AZN stock is great to own, but you should choose your entry points carefully, as AstraZeneca has some short-term risks ahead.
The stock charts of PGR, LB and PKG are going to start the new trading week on the cusp of major moves that have been forming for weeks.
AstraZeneca announced that it has inked a deal with Daiichi Sankyo to improve its oncology branch. AZN stock is down more than 5% on Friday.
An AstraZeneca earnings beat for the pharmaceutical company's fourth quarter of 2018 has AZN stock heading higher on Thursday.
Don't ignore Dow Jones stocks. They can still power your portfolio. Here are 5 of the best to own in 2019 and beyond!
AstraZeneca's profits are poised to accelerate, but investors should wait for AZN stock to break out of its range before buying the shares.
BIIB stock jumped on Friday, and for good reason. It's not a buy at these lofty levels, but Biogen has at least earned a spot on your watchlist.
Though the large-cap pharma industry is struggling currently, there are a few stocks that are performing well. Compare Brokers....
The Food and Drug Administration (FDA) announced a list of drug makers that have tried to block generic drugs in its new shame list. Here they are.
AstraZeneca plc (AZN) stock was down on Friday following the release of its earnings report for the first quarter of 2018.
Here we discuss three emerging technologies, which the pharma/biotech industry has started adopting, albeit slowly. These are poised to transform the sector by....
Merck & Co's cancer drug, Keytruda, saw explosive growth this quarter, making MRK stock a tough name to handicap right now.
Portfolio Grader currently ranks AstraZeneca Plc (NYSE:AZN) a Buy. With unique fundamental and quantitative metrics developed by Louis Navellier, this analytical tool evaluates nearly 5,000 stocks weekly. The current Portfolio Grader recommendation on the shares has been in place for the last month.
From Seeking Alpha
Pintec Technology (NASDAQ:PT) expanded its cooperation with Industrial and Commercial Bank of China (ICBC), to provide SME risk management solutions for its micro and small-sized lending business.Pintec's solutions such as machine-learning models have bolstered the ICBC’s decision-making capabilities, and enabled to double the accuracy rate of its early risk warning models.With this progress, Pintec and ICBC has completed the first stage of the cooperation.
Industrial and Commercial Bank of China Limited (HKG:1398) Looks Like A Good Stock, And It’s Going Ex-Dividend Soon
From Simply Wall St
Readers hoping to buy Industrial and Commercial Bank of China Limited (HKG:1398) for its dividend will need to make their move shortly, as the stock is about to trade ex-dividend.<div><a class="permalink" href="https://simplywall.st/stocks/hk/banks/hkg-1398/industrial-and-commercial-bank-of-china-shares/news/industrial-and-commercial-bank-of-china-limited-hkg1398-looks-like-a-good-stock-and-its-going-ex-dividend-soon/">Read More...</a></div>
From Simply Wall St
The big shareholder groups in Industrial and Commercial Bank of China Limited (HKG:1398) have power over the company. Generally speaking, as a company grows, institutions will increase their ownership. Conversely,<div><a class="permalink" href="https://simplywall.st/stocks/hk/banks/hkg-1398/industrial-and-commercial-bank-of-china-shares/news/what-kind-of-investor-owns-most-of-industrial-and-commercial-bank-of-china-limited-hkg1398/">Read More...</a></div>
Navellier RatingsPowered by Portfolio Grader